Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 29, 2024
Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort AnalysisRachel S Newson, Victoria Divino, Kristina S Boye, et al.
Pharmacological Research|May 6, 2008
Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: a 4-year retrospective study from national primary care dataGiampiero Mazzaglia, Nicole Yurgin, Kristina S Boye, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 20, 2007
Utilities and disutilities for type 2 diabetes treatment-related attributesLouis S Matza, Kristina S Boye, Nicole Yurgin, et al.
Obesity Pillars|November 11, 2025
Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 clinical trialIris A Goetz, Chisom Kanu, Anastasia Hoover, et al.
Diabetes, Obesity & Metabolism|November 18, 2025
The value and impact of weight reduction from the perspective of people with type 2 diabetes in the United StatesMelissa M Ross, Sarah Mulnick, Kristina S Boye, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 10, 2020
Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelinesMatthew Kennedy-Martin, Bernhard Slaap, Michael Herdman, et al.
Patient Preference and Adherence|May 4, 2026
Differences in Perspectives of Weight Management Among People in the US and Canada with Type 2 Diabetes by Body Mass IndexMelissa M Ross, Sarah Mulnick, Kristina S Boye, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 28, 2015
The time horizon matters: results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitationLouis S Matza, Kristina S Boye, David H Feeny, et al.
Drugs in R&D|May 23, 2019
Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UKKristina S Boye, Dara Stein, Louis S Matza, et al.
Journal of Diabetes Science and Technology|April 10, 2013
Understanding heterogeneity in response to antidiabetes treatment: a post hoc analysis using SIDES, a subgroup identification algorithmDana S Hardin, Rachelle D Rohwer, Bradley H Curtis, et al.
Pageof 13